WeVote
Log In

Bill

Bill

SB 466

Defining drugs as adulterated when they contain specified food dyes and additives

2026 Regular Session

West Virginia bill prohibits drugs containing specified food dyes and additives, aiming to reduce potentially harmful ingredients in medications but risking manufacturing complexity and drug availability issues.

0
WeVote Research Nonpartisan
Bill Summary · SB 466

Legislative bill overview

SB 466 classifies pharmaceutical drugs as "adulterated" if they contain certain food dyes and additives, establishing stricter standards for drug manufacturing in West Virginia. The bill would prohibit the use of these colorants and additives in medications sold or distributed within the state.

Why is this important

Food dyes and additives in medications have faced increasing scrutiny over potential health effects, particularly in children. This bill reflects growing consumer concern about unnecessary ingredients in drugs, though it could create compliance challenges for pharmaceutical manufacturers and potentially limit drug availability if federal regulations differ from state standards.

Potential points of contention

  • Regulatory alignment: Federal FDA approval does not automatically authorize these additives in drugs; however, a state-level ban could create a patchwork of differing requirements across states, complicating manufacturing and distribution
  • Drug availability and cost: Reformulating medications to comply with West Virginia standards could reduce options available to patients or increase drug prices if manufacturers must create state-specific versions
  • Scientific evidence: The specific health risks warranting prohibition of particular additives may lack definitive scientific consensus, raising questions about whether the restrictions are based on precautionary principle or established harm

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.